A retrospective analysis of memantine use in a pediatric neurology clinic

Author(s):  
Sarah Bouhadoun ◽  
Chantal Poulin ◽  
Saoussen Berrahmoune ◽  
Kenneth A. Myers
Author(s):  
Emre Sarıkaya ◽  
Halûk Yavuz

AbstractNeurological problems constitute an important part of diseases in children. Studies evaluating neurological diseases in children collectively and reporting their types and rates are very few. We report the clinical and laboratory spectra of children presenting with neurological diseases to our clinic. The charts of patients who presented for the first time to the only pediatric neurology outpatient clinic in the region during a year were evaluated retrospectively. A total of 88,785 patients were seen at the Meram Faculty of Medicine pediatric outpatient clinics in 1 year; 5.5% (4,904) of these patients were seen at the child neurology clinic and 1,807 patients (36.8%) were seen for the initial evaluation. Medical charts of 1,685 (93.2%) patients were reviewed: 952 (56.5%) were male patients and 733 were females. The mean age was 5.77 ± 4.92 years; 30.9% of the patients had a similar disease in the family. The top three presenting complaints that led to hospital seen were seizures (12.2%), paroxysmal events (10%), and headaches (9.2%). The most common diagnoses were epilepsy (18%), headache (8.6%), and developmental delay (7.8%). Our study describes the characteristics of the large number of patients seen for the first time in the child neurology outpatient clinic.


2021 ◽  
Author(s):  
Jacob Genizi ◽  
Dana Lahoud ◽  
Rony Cohen

Abstract Migraine headaches in children may cause attacks that require abortive treatment. This study evaluated the incidence and efficacy of medications used for relieving migraine headache attacks in the pediatric population in Israel. Children 6–18 years of age who were diagnosed in our pediatric neurology clinic as having migraine headaches were enrolled into the study. Children and their parents recorded the children response to abortive treatment during three consecutive migraine attacks. Fifty children, with 116 migraine attacks, were included in the study (30 females; mean age 12; range 6–18). Forty-seven (94%) reported on abortive treatment on the first migraine attack, 43 (86%) on a second migraine attack and 26 (52%) on a third migraine attack. During the first recorded migraine attack, 41 children (87.5%) reported taking only one type of medication for each headache episode, mainly ibuprofen or acetaminophen; less than a quarter used dipyrone. The improvement rate after two hours was 65.4%±27 for ibuprofen, 59.8±35.3 for acetaminophen and 50.9±27.4 for dipyrone. In conclusion, Children with migraine in Israel mainly use a single medication for each headache episode. Ibuprofen is the most commonly used abortive treatment; however, acetaminophen was associated with a better response.


2018 ◽  
Vol 35 (5-6) ◽  
pp. 118-23
Author(s):  
Taslim S Soetomenggolo

During two years, 92 patients who experienced first febrile convulsion were followed-up in the Pediatric Neurology Clinic, Department of Child Health, Cipto Mangunkusumo Hospital, Jakarta for at least one year. Of the 92 patients 58 (63%) were males and 34 (37%) females. Most of the patients were less than 4 years, and only 6 patients (6,5%) aged more than 4 years. Eight (8, 7%) of the 92 patients suffered from recurrence of febrile convulsions, and in 5 of them the recurrence occurred within the first 6 months of follow-up. The recurrences of febrile convulsions occurred mostly in patients less than one year of age, those with tonic seizures, those with neurological disorders, and those who had history of epilepsy in their family. In this study the occurrence of recurrent febrile convulsions in patients with normal EEG was higher than that in patients with abnormal EEG.


Author(s):  
Isaac Soo ◽  
Jean K. Mah ◽  
Karen Barlow ◽  
Lorie Hamiwka ◽  
Elaine Wirrell

ABSTRACT:Background:Complementary and alternative medicine (CAM) is increasingly used in adults and children. Studies on CAM in neurological disorders have focused on the adult population and its use among pediatric neurology patients has not been well characterized.Objectives:The purpose of this study was: 1) To characterize the prevalence of CAM in pediatric neurology patients; 2) To determine the perceived effectiveness of CAM in these children; 3) To compare the cost of CAM with conventional therapies; and 4) To describe caregiver or patient-related variables associated with the use of CAM.Methods:This was a cross-sectional survey of patients and families attending the Alberta Children's Hospital neurology clinic between February and May 2004. Patients were considered eligible if they were between two and 18 years of age and had a known history of neurological disorders. Caregivers completed several self-administered questionnaires regarding their socio-demographic profile, their child's neurological illness, and their experience with CAM. Caregivers also rated their child's quality of life using the Pediatric Quality of Life Inventory.Results:One hundred and five of 228 (46%) families completed the survey. The mean age of the neurology patients was 9.8 ± 4.5 years. Forty-six (44%) out of 105 patients received one or more types of CAM, with the most common types being chiropractic manipulations (15%), dietary therapy (12%), herbal remedies (8%), homeopathy (8%), and prayer/faith healing (8%). Caregivers' sociodemographic variables or pediatric health-related quality of life were not significantly associated with the use of CAM. Fifty-nine percent of CAM users reported benefits, and only one patient experienced side effects. There was no significant difference in the total median cost of CAM compared to conventional therapies ($31.70 vs. $50.00 per month). Caregivers' personal experience or success stories from friends and media were common reasons for trying CAM.Conclusions:The use of CAM was common among pediatric neurology patients. Over half of the families reported benefits with CAM, and side effects were perceived to be few. Physicians should initiate discussion on CAM during clinic visits so that the families and patients can make informed decisions about using CAM. Further studies should address the specific role of CAM in children with neurological disorders, and to determine the potential interactions between CAM and conventional therapies in these patients.


Author(s):  
J.M. Dooley ◽  
K.E. Gordon ◽  
E.P. Wood

Background:There is little data available on the acceptability to parents, of alternate methods of delivering care to their children. This pilot study explored parents'perceptions of conventional clinic visits and their attitudes to potential alternative methods of delivering care.Methods:Questionnaires were completed by the families of 200 consecutive children before and after a visit to a tertiary-care Pediatric Neurology Clinic in Nova Scotia, Canada.Results:Responses were received from 172 (86%) for the first questionnaire and 138 (69%) for the second. There were 59 new referrals, 76 follow-up visits and 39 were seen because of new concerns. Visiting the clinic resulted in school absenteeism for 85% of the children and lost pay for 19% of the parents. Telephone, video conference or replacement of the physician by a nurse practitioner were acceptable alternate methods of assessment for only 10%. The only factor which was associated with willingness to accept telephone as an assessment modality was an initial opinion that the visit was unnecessary.Conclusion:Escalating health care costs and limited specialist availability demand consideration of alternate methods of care delivery. Although adults seem comfortable with care outside the usual clinic setting, there is little data for the pediatric setting. The responses from the parents attending our clinic, indicate that families were happy with services offered in the conventional clinic. In contrast, only 10% found potential alternate methods acceptable. These opinions must be considered in the design of new methods of caring for children.


Biofeedback ◽  
2009 ◽  
Vol 37 (4) ◽  
pp. 126-128
Author(s):  
Nancy H. Christie

Abstract Biofeedback for pediatric headache has been well established over the past 25 years. Biofeedback has traditionally been practiced and applied in hospitals, pain clinics, chemical dependency facilities, universities, and private practices. The purpose of this article is to share the author's experience working in a children's medical center in the neuroscience division and to encourage readers to pursue work in untapped, high-potential settings that could greatly benefit from this vital service. This article will detail how biofeedback has been used and integrated into a pediatric neurology clinic.


Sign in / Sign up

Export Citation Format

Share Document